---
$id: https://graph.org.ai/products/commodity/51111833
$type: Product
source: UNSPSC
code: "51111833"
title: "Axitinib"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Axitinib

**UNSPSC Code**: 51111833
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C22H18N4OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C9LVQ0YUXG. European Medicines Agency schedules axitinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25427. The term AXITINIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56. ). Most nations schedule axitinib under HS 29333990 and SITC 51574. As of Q4 2014, AXITINIB remains the US FDA Preferred Term for this commodity. Axitinib bears US NLM identifiers UMLS ID C1700874 and NCI Concept Code C38718. SMILES: S(C1CC2[NH]NC(C2CC1)/C=C/C1NCCCC1)C1C(CCCC1)C(=O)NC.

